Ambiq Micro, Inc. (NASDAQ:AMBQ) disclosed that its Chief Technology Officer and Director, Scott McLean Hanson, sold 7,000 shares of company common stock on November 16, 2026, for total proceeds of $308,244. The sales were executed immediately following the exercise of stock options covering an identical number of shares at $8.12 per share, amounting to $56,839. Both the option exercise and the subsequent sales were conducted under a Rule 10b5-1 trading plan that Hanson adopted on May 15, 2026.
The disposition was carried out in three separate transactions. Hanson first sold 4,084 shares at a weighted average price of $43.848 per share, with individual trades ranging from $43.11 to $44.09. A second block of 2,900 shares was sold at a weighted average price of $44.2921, with prices between $44.11 and $44.71. A final lot of 16 shares was sold at $45.12 per share.
The options underlying the exercise were part of a grant with a vesting schedule that commenced on August 16, 2019, when one-quarter of the shares vested. The remaining shares vest in equal monthly installments thereafter, subject to Hanson’s continued service. After these transactions, Hanson directly holds 212,546 shares of Ambiq Micro common stock and 31,279 derivative securities in the form of stock options.
The insider sale comes as AMBQ shares, currently trading at $45.90, have declined roughly 6% over the past week and sit about 50% below their 52-week high of $91.61. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value and is featured on the platform’s most overvalued stocks list. Despite recent weakness, the company with a market cap of $1.14 billion has delivered a strong 95% return over the past year.
In other recent news, Ambiq Micro reported impressive financial results for the third quarter of fiscal 2026, with revenue reaching $38.14 million, marking a 110% increase year-over-year. This revenue figure exceeded the company’s guidance, driven by growth across various customer segments, product families, and form factors. Despite posting a net loss, Ambiq Micro significantly narrowed its adjusted loss per share to $0.05, surpassing analyst expectations of a $0.33 loss. The company also reported an improved non-GAAP gross margin of 48.7%, a 390 basis point increase from the previous year. Additionally, Ambiq Micro ended the quarter with $363.5 million in cash and no debt, highlighting a strong financial position. Stifel, maintaining a Buy rating, adjusted its price target for Ambiq Micro to $70 from $85, citing sector-wide challenges in the chip industry. Analysts noted the company’s continued growth momentum and broad-based demand rather than mere inventory replenishment. Despite these positive developments, investors showed caution, as reflected in the premarket trading of Ambiq Micro shares.